CGON CG Oncology, Inc.
62.38USD-1.98%Mkt Cap: 5.53B $P/E: —1d ago
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company's product candidate is cre…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap5.53B USD
Enterprise Value4.62B USD
Revenue (TTM)6.23M USD
Gross Profit-607.00K USD
Net Income (TTM)-161.00M USD
Revenue/Share0.08 USD
Last Price62.38 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees142
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-21.07
PEG—
EV/EBITDA-18.51
EV/Revenue742.07
P/S905.76
P/B5.46
EPS (TTM)-2.69
EPS (Forward)-3.02
52W Range
35.6459% of range80.97
52W High80.97 USD
52W Low35.64 USD
Profitability
Gross Margin-15.02%
Oper. Margin-7467.68%
EBITDA Margin0.00%
Profit Margin-3985.02%
ROE-21.39%
ROA-20.34%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-132.35M USD
CapEx (TTM)134.00K USD
FCF Margin-1825.78%
FCF Yield-2.06%
Net Debt-1.02B USD
Net Debt/EBITDA4.08
Balance Sheet
Debt/Equity0.01
Current Ratio22.22
Quick Ratio21.78
Book Value/Sh11.65 USD
Cash/Share11.60 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)91.08 USD
Upside (mean)+46.0%
Target Range79.00 USD – 108.00 USD
79.00+46.0% to mean108.00
# Analysts13
Ownership
Shares Out.88.64M
Float68.28M
Insiders0.23%
Institutions113.64%
Short Interest
Short Ratio16.1d
Short % Float12.92%
Short % Out.12.70%
Shares Short11.25M
Short (prev mo.)11.25M
Technical
SMA 5073.98 (-15.7%)
SMA 20064.06 (-2.6%)
Beta0.28
S&P 52W Chg16.45%
Avg Vol (30d)908.90K
Avg Vol (10d)1.25M
Technical Indicators
RSI (14)33.1
MACD-2.3232
MACD Signal-1.3354
MACD Hist.-0.9878
BB Upper78.97 USD
BB Middle70.87 USD
BB Lower62.77 USD
BB Width22.87%
ATR (14)3.457 USD
Vol Ratio (20d)0.62x